VENTAVIS Israel - English - Ministry of Health

ventavis

bayer israel ltd - iloprost - solution for inhalation - iloprost 0.01 mg/ml - iloprost - treatment of patients with primary pulmonary hypertension (pph) or secondary pulmonary hypertension (sph) . due to connective tissue disease or drug - induced, in moderate or severe stages of the disease. in addition, treatment of moderate or severe secondary pulmonary hypertension due to chronic pulmonary thromboembolism, where surgery is not possible.

ILOMEDIN Israel - English - Ministry of Health

ilomedin

bayer israel ltd - iloprost - concentrate for solution for infusion - iloprost 0.1 mg/ml - iloprost - iloprost - peripheral arterial occlusive disease (stage 3 and 4 of fontaine's classification) in advanced arteriosclerosis, in whom surgery or angioplasty therapy is not possible.thromboangitis obliterans (buerger's disease) with critical limb ischemia in cases where revascularisation is not indicated and severe disabling raynaud's phenomenon .

VENTAVIS SOLUTION FOR INHALATION Singapore - English - HSA (Health Sciences Authority)

ventavis solution for inhalation

bayer (south east asia) pte ltd - iloprost trometamol 0.013 mg/ml eqv iloprost - solution - 0.010 mg/ml - iloprost trometamol 0.013 mg/ml eqv iloprost 0.010 mg/ml

Ventavis European Union - English - EMA (European Medicines Agency)

ventavis

bayer ag - iloprost - hypertension, pulmonary - antithrombotic agents - treatment of patients with primary pulmonary hypertension, classified as new york heart association functional class iii, to improve exercise capacity and symptoms.